About Elizabeth Scott
Elizabeth Scott is a chief executive officer and director at Renovare Therapeutics.
Experience
This experience comes from Elizabeth Scott's profile and from SEC filings. For roles taken from filings, the years are when the filings name Elizabeth Scott in the role, so the role may have started earlier or lasted longer.
Renovare Therapeutics, Inc. Current
Chief Executive Officer and director
2025 – Present · Boulder, CO
Develops regenerative treatments for people with osteoarthritis.
KA
KARITHERA
Fractional CEO
2025 – 2026
AI
Applied Therapeutics, Inc.
Vice President of Sales
2024 – 2025
FC
Fairview Consulting, LLC - Strategic Pharma/Biotech Commercial Consulting
Founder & Principal
2023 – 2024
RI
Reata Pharmaceuticals, Inc.
Vice President, Head of Marketing & Pipeline Strategy
2021 – 2023
BI
BioCryst Pharmaceuticals, Inc.
Regional Business Director, West
2020 – 2021
AI
Array BioPharma Inc.
Head of Marketing, Senior Director
2018 – 2020
GE
Genentech
Assoc. Director, Pipeline Portfolio Management & Commercialization, Immunology & Ophthalmology
2010 – 2018
TG
The Ruth Group
Assistant Vice President, Healthcare Investor Relations
2007 – 2008
TC
Tefen Management Consulting
Marketing/Business Development Specialist, Health Care Consulting
2005 – 2007
GD
Genencor, A Danisco Division
Research Assistant (Protein Purification)
2004 – 2005
Key Colleagues at Startups
The people Elizabeth Scott works with at each company, as listed on that company's latest Form D.
Renovare Therapeutics, Inc. · Form D, Oct 2, 2026
Stephanie Bryant
Chief Scientific Officer and director
Karin Payne
Chief Development Officer